Scales Charles D, Wiener John S
Duke University Medical Center, Durham, North Carolina 27710, USA.
J Urol. 2008 Dec;180(6):2323-9. doi: 10.1016/j.juro.2008.08.050. Epub 2008 Oct 18.
The urological complications of spina bifida impose a significant burden of disability and disease. Therapy is focused on the bladder to achieve the primary goals of maintaining normal renal function and attaining urinary continence. When medical management fails, surgical intervention, including enterocystoplasty, is frequently performed. However, practice patterns for enterocystoplasty show significant variation. Given this context, we examined outcome measures for enterocystoplasty in patients with spina bifida.
A MEDLINE search was performed for articles on enterocystoplasty in patients with spina bifida. A total of 226 articles were identified and manually reviewed for relevant studies. Additional articles were selected based on a cited reference search.
Almost all studies are retrospective, single institution case series of a relatively small number of patients. Few uniform or validated outcome measures for enterocystoplasty exist but reported measures typically include urodynamic, continence and satisfaction parameters. Interinstitutional variability in urodynamic measurements and in definitions of continence makes a comparison of outcomes difficult. The complication rate following enterocystoplasty is significant, well described and primarily related to the use of gastrointestinal segments for urine storage.
Medical management is the mainstay of neurogenic bladder therapy in the spina bifida population. Enterocystoplasty remains an important option to prevent or reverse upper tract deterioration, and/or improve or cure socially unacceptable incontinence despite poorly defined outcome measures. The development of appropriate and validated outcomes measures may enable more uniform, effective and safe urological care of patients with spina bifida.
脊柱裂的泌尿系统并发症会带来严重的残疾和疾病负担。治疗重点在于膀胱,以实现维持正常肾功能和实现尿失禁这两个主要目标。当药物治疗失败时,通常会进行包括肠膀胱扩大术在内的手术干预。然而,肠膀胱扩大术的实践模式存在显著差异。在此背景下,我们研究了脊柱裂患者肠膀胱扩大术的疗效指标。
对关于脊柱裂患者肠膀胱扩大术的文章进行了医学文献数据库(MEDLINE)检索。共识别出226篇文章,并对相关研究进行了人工审查。根据引用参考文献检索选择了其他文章。
几乎所有研究都是回顾性的、单机构的少量患者病例系列。几乎没有统一或经过验证的肠膀胱扩大术疗效指标,但报告的指标通常包括尿动力学、尿失禁和满意度参数。尿动力学测量和尿失禁定义的机构间差异使得结果比较困难。肠膀胱扩大术后的并发症发生率很高,已有充分描述,且主要与使用胃肠道段储存尿液有关。
药物治疗是脊柱裂患者神经源性膀胱治疗的主要方法。尽管疗效指标尚不明确,但肠膀胱扩大术仍然是预防或逆转上尿路恶化和/或改善或治愈社会上不可接受的尿失禁的重要选择。制定合适且经过验证的疗效指标可能会使脊柱裂患者获得更统一、有效和安全的泌尿外科护理。